erlotinib has been researched along with ro 31-7549 in 1 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (ro 31-7549) | Trials (ro 31-7549) | Recent Studies (post-2010) (ro 31-7549) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 77 | 0 | 7 |
| Protein | Taxonomy | erlotinib (IC50) | ro 31-7549 (IC50) |
|---|---|---|---|
| 3-phosphoinositide-dependent protein kinase 1 | Homo sapiens (human) | 1 | |
| cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 5.2 | |
| Protein kinase C alpha type | Rattus norvegicus (Norway rat) | 0.075 | |
| Protein kinase C gamma type | Rattus norvegicus (Norway rat) | 0.075 | |
| Protein kinase C beta type | Rattus norvegicus (Norway rat) | 0.075 | |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | Homo sapiens (human) | 0.31 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 1.05 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balke-Want, H; Basu, D; Engel, J; Ercanoglu, MS; Rauh, D; Richters, A; Tesch, R; Thomas, RK | 1 |
1 other study(ies) available for erlotinib and ro 31-7549
| Article | Year |
|---|---|
Identification and further development of potent TBK1 inhibitors.
Topics: Animals; Cell Line; Drug Design; Humans; Macrophages; Mice; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Small Molecule Libraries; Structure-Activity Relationship | 2015 |